CN101579340A - Composite medicine preparation for treating gastro-enteritis and gastric ulcer - Google Patents
Composite medicine preparation for treating gastro-enteritis and gastric ulcer Download PDFInfo
- Publication number
- CN101579340A CN101579340A CNA2009101487216A CN200910148721A CN101579340A CN 101579340 A CN101579340 A CN 101579340A CN A2009101487216 A CNA2009101487216 A CN A2009101487216A CN 200910148721 A CN200910148721 A CN 200910148721A CN 101579340 A CN101579340 A CN 101579340A
- Authority
- CN
- China
- Prior art keywords
- course
- hours
- gastric ulcer
- day
- enteritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a composite medicine preparation for treating gastro-enteritis and gastric ulcer. The composite preparation comprises the following components: three pieces of berberine of 0.1g, four pieces of furazolidone of 0.1g and three pieces of vitamin B6 of 0.5g. The composite preparation has one course for a week, in the first course, administration is carried out for each day with every four hours, and one course can be effective. In the second course, administration is carried out for each day with every six hours; in the third course, administration is carried out for each day with every 8 hours, then the gastrointestinal diseases of gastro-enteritis, gastric ulcer and the like can be radically treated thoroughly. A patient can not drink wine in the courses. In order to consolidate the curative effect, another course can be added, and in the fourth course, administration is carried out for each day with every 8 hours. The invention can cure the gastrointestinal diseases of stomachache, gastric acid, gastrectasia, diarrhea, stomach heat, stomach cold and the like thoroughly.
Description
Technical field
The present invention relates to a kind of combination drug for the treatment of gastroenteritis, gastric ulcer.
Background technology
Gastroenteritis is a kind of commonly encountered diseases, frequently-occurring disease.Many because due to the infection such as antibacterial and virus.Mainly show as the diarrhoea and the abdominal discomfort of upper digestive tract condition of illness and varying degree, occur losing of electrolyte and liquid subsequently.Primary disease belongs to traditional Chinese medical science disease categories such as " vomiting, stomachache, diarrheas ".
Acute gastroenteritis is because food advances to contain the food of pathogen and toxin thereof, or improper diet, and the acute inflammation of the intestines and stomach mucosa that causes as excessive excitatory stodgy food sexually revises.China with summer, two season of autumn sickness rate higher, asexuality difference, be 12～36 hours general incubation period.
Salmonella is the The main pathogenic fungi that causes acute gastroenteritis, and is wherein comparatively common with Salmonella typhimurium, Salmonella enteritidis, Salmonella choleraesuls, Salmonella gallinarum, Salmonella anatis.
Mainly show as nauseating, the vomiting, stomachache, diarrhoea; Heatings etc., severe patient can cause dehydration, electrolyte disturbance, shock etc.That patient shows as more is nauseating, vomiting formerly; Continue with diarrhoea, every day 3-5 time even tens of days are not waited, and stool is water sample more, and buff or band are green, and stench can be with symptoms such as abdominal colic, heating, systemic pain.
Gastric ulcer also is a kind of commonly encountered diseases.Epidemiological study shows, has 10% to suffer from primary disease in life at it in the population approximately.Gastric ulcer can betide any age, 45-55 year to see that at most on sex, masculinity and femininity is basic identical, male's slight superiority.Various factors relevant such as gastric acid, pepsin, helicobacter pylori infections, heredity, body constitution, environment, diet, living habit, neural Nervous and Mental Factors etc. with morbidity, by different approaches or mechanism, cause above-mentioned invasion and attack effect enhancing out of funds and or preventing mechanism weaken, all can inspire ulcer and take place.
Think that at present peptic ulcer is a kind of multi-pathogenesis disease.Various factors relevant such as gastric acid, pepsin, infection, heredity, body constitution, environment, diet, living habit, neural Nervous and Mental Factors etc. with morbidity, by different approaches or mechanism, cause above-mentioned invasion and attack effect to strengthen and or preventing mechanism weaken, all can inspire ulcer and take place.
One, gastric acid and pepsic invasion and attack effect and influence factor.
1. the effect of gastric acid one pepsic invasion and attack effect, especially gastric acid, in ulcer in the highest flight.
2. neural Nervous and Mental Factors.Continue, over-drastic psychentonia, fatigue, neural Nervous and Mental Factors such as excited often be the key factor of the generation and the recurrence of duodenal ulcer.
3. helicobacter pylori system causes one of key factor of peptic ulcer.
Summary of the invention
The technical issues that need to address of the present invention just are to provide a kind of combination drug for the treatment of gastroenteritis, gastric ulcer, and it can thoroughly cure stomachache, gastric acid, flatulence, diarrhoea, the gastric heat that the acute and chronic gastritis enteropathy causes, gastroenteropathys such as cold syndrome of the stomach.
For addressing the above problem, the present invention adopts following technical scheme:
A kind of combination drug for the treatment of gastroenteritis, gastric ulcer of the present invention, described compound preparation is by 3 of the berberines of 0.1 gram, 4 of the furazolidones of 0.1 gram and the vitamin B of 0.5 gram
63 compositions.
One week of compound preparation of the present invention is a course of treatment, and per 4 hours of first every day course of treatment took once, and just can take effect a course of treatment.Take once second per 6 hours of every day course of treatment; Take once the 3rd per 8 hours of the every day course of treatment, can thoroughly effect a radical cure gastrointestinal disease such as gastroenteritis, gastric ulcer.Can not drink during taking.For consolidating curative effect, can increase a course of treatment again, take once the 4th per 8 hours of the every day course of treatment.
Compound preparation of the present invention is used for stomach discomfort, thoroughly cures the stomachache that the acute and chronic gastritis enteropathy causes, gastric acid, flatulence, diarrhoea, gastric heat, gastroenteropathys such as cold syndrome of the stomach.Therapeutic effect is remarkable.
Berberine is a kind of important alkaloid, is that China uses Chinese medicine for a long time.Can from plants such as Rhizoma Coptidis, Cortex Phellodendri, Radix Berberidis, extract.It has significant bacteriostasis.Berberine hydrochloride commonly used is berberine hydrochloride again, and its chemical constitution as shown in the figure.Berberine energy enantiopathy pathogenic microorganism, various bacteria such as dysentery bacterium, tubercule bacillus, streptococcus pneumoniae, Bacillus typhi and diphtheria corynebacterium etc. all there is inhibitory action, wherein the strongest to the dysentery bacterium effect, be commonly used to treat digestive tract disease such as bacillary gastroenteritis, dysentery.Clinical being mainly used in treated bacillary dysentery and gastroenteritis, its no Drug resistance and side effect.Explaining that with Chinese medicine this type of medicine is cool in nature, can remove pathogenic heat or deficiency-heat, remove harmful poisonous substance, is exactly the good medicine of heat-clearing and toxic substances removing simply in the traditional Chinese medical science hands since ancient times.
Furazolidone be the similar furan of antimicrobial spectrum because of.The most responsive to escherichia coli, dysentery bacterium etc.But intestinal is difficult for absorbing when oral.
Vitamin B6 is adermin again, and how hot pyrrole is, is a kind of water soluble vitamins.Digest and excreted with interior meeting in back 8 hours.The same with other vitamin B group, need food or nutritional supplement to replenish; The set that vitamin B6 is actually by several materials--pyridoxol, 2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine., pyridoxamine--has confidential relation and mutual effect each other.
The present invention has good especially effect with above-mentioned 3 kinds of medicine immixtures to treatment gastroenteritis, gastric ulcer.
The specific embodiment
A kind of combination drug for the treatment of gastroenteritis, gastric ulcer of the present invention, described compound preparation is by 3 of the berberines of 0.1 gram, 4 of the furazolidones of 0.1 gram and the vitamin B of 0.5 gram
63 compositions.
One week of compound preparation of the present invention is a course of treatment, and per 4 hours of first every day course of treatment took once, and just can take effect a course of treatment.Take once second per 6 hours of every day course of treatment; Take once the 3rd per 8 hours of the every day course of treatment, can thoroughly effect a radical cure gastrointestinal disease such as gastroenteritis, gastric ulcer.Can not drink during taking.For consolidating curative effect, can increase a course of treatment again, take once the 4th per 8 hours of the every day course of treatment.
The tradition medicine for enterogastritis is long the course of treatment, and it is slow to take effect, gastroenteropathy relapse rate height.With compound preparation treatment gastroenteropathy instant effect of the present invention, curative effect is lasting, reduces outbreak, breaks traditions.
Tradition the intestines and stomach Drug therapy gastroenteropathy, relapse rate is up to more than 90% in 1 year, and through clinical trial certificate, compound preparation of the present invention can effectively be repaired the intestines and stomach mucosa, and the radical rate height is difficult for recurrence.
Gastroenteropathy patient does not generally feel like a meal, or wants to eat and dare not eat.Compound preparation of the present invention is broken a deadlock, and the initial stage of taking just can appetite strengthening, allows you want just to eat and eat.
Many gastroenteropathy patient treatment gastroenteropathy fall other disease all over the body on the contrary.Compound preparation safety of the present invention has no adverse reaction, and cures the disease and is not harmful to the health, and allows the gastroenteropathy patient be without fear of an attack from the rear, and fundamentally cures gastroenteropathy.
The gastroenteropathy obstinate, the danger of canceration is big; Compound preparation of the present invention is controlled, supports, protects three-in-one, can reduce the human primary gastrointestinal cancers probability, can treat human primary gastrointestinal cancers again, improves body immune function.
It should be noted that at last: above embodiment only in order to the explanation the present invention and and unrestricted technical scheme described in the invention; Therefore, although this description has been described in detail the present invention with reference to each above-mentioned embodiment,, those of ordinary skill in the art should be appreciated that still and can make amendment or be equal to replacement the present invention; And all do not break away from the technical scheme and the improvement thereof of the spirit and scope of the present invention, all should be encompassed in the claim scope of the present invention.
Claims (1)
1, a kind of combination drug for the treatment of gastroenteritis, gastric ulcer is characterized in that: described compound preparation is by 3 of the berberines of 0.1 gram, 4 of the furazolidones of 0.1 gram and the vitamin B of 0.5 gram
63 compositions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009101487216A CN101579340A (en) | 2009-07-01 | 2009-07-01 | Composite medicine preparation for treating gastro-enteritis and gastric ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009101487216A CN101579340A (en) | 2009-07-01 | 2009-07-01 | Composite medicine preparation for treating gastro-enteritis and gastric ulcer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101579340A true CN101579340A (en) | 2009-11-18 |
Family
ID=41361747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2009101487216A Pending CN101579340A (en) | 2009-07-01 | 2009-07-01 | Composite medicine preparation for treating gastro-enteritis and gastric ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101579340A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006973A (en) * | 2013-01-10 | 2013-04-03 | 方奋宗 | Stomach-nourishing health-care product preparation and preparation method thereof |
-
2009
- 2009-07-01 CN CNA2009101487216A patent/CN101579340A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006973A (en) * | 2013-01-10 | 2013-04-03 | 方奋宗 | Stomach-nourishing health-care product preparation and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102698123B (en) | Traditional Chinese medicinal composition for treating transmissible gastroenteritis of swine, feed, preparation method and application thereof | |
| CN102526525B (en) | Traditional Chinese medicine composition for treating transmissible gastroenteritis of swine | |
| CN101273778A (en) | Honeysuckle cold tea and method for preparing the same | |
| CN101850008A (en) | Bacillus Ling oral liquid and preparation method thereof | |
| CN102125660B (en) | Traditional Chinese medicine sustained-release micro granules stomach and intestine partner for protecting and strengthening functions of stomach and intestine | |
| CN104548015B (en) | A kind of medicine for treating chronic colitis | |
| CN101507762A (en) | Veterinary medicine for treating colibacillosis and white dysentery | |
| CN101411717B (en) | Composition for treating acute enteritis and diarrhea | |
| CN101306180B (en) | Gastropathy treating medicine | |
| CN103405628A (en) | Traditional Chinese medicine oral liquid for treating respiratory diseases of livestock and poultry | |
| CN101972391A (en) | Medicinal composition used for treating swine mastitis and preparation method thereof | |
| CN103816323A (en) | Pill for treating helicobacter pylori related gastritis | |
| CN104523897B (en) | A kind of enema medicament composition for treating piglet epidemic diarrhea | |
| CN101579340A (en) | Composite medicine preparation for treating gastro-enteritis and gastric ulcer | |
| CN104306888A (en) | Traditional Chinese medicine for treating chronic gastroenteritis | |
| CN104147524A (en) | Traditional Chinese medicine preparation for treating peptic ulcer | |
| CN100527998C (en) | Herbal meal of gastrointestinal sustained release particle for protecting gastrointestinal mucosa | |
| CN114377071A (en) | Traditional Chinese medicine enema and preparation method thereof | |
| CN104888026A (en) | Traditional Chinese medicine recipe for treating pneumonia | |
| CN104116960A (en) | Traditional Chinese medicinal preparation for treating hand-foot-and-mouth disease | |
| CN110538218A (en) | Composition for treating mastitis | |
| CN103820277A (en) | Physalis alkekengi heat-clearing detoxifying wine and production method thereof | |
| CN1264563C (en) | Gastropathy treating medicine and its preparation | |
| CN106266437A (en) | A kind of Integrated TCM preparation treating bacillary dysentery and preparation method | |
| CN102000295B (en) | Chinese material medical preparation used for treating gastritis and gastric ulcer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20091118 |